Search

Your search keyword '"Cao, Davide"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Cao, Davide" Remove constraint Author: "Cao, Davide" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
48 results on '"Cao, Davide"'

Search Results

1. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease

3. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program

4. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review

5. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review

6. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention

7. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI

8. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions

9. Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries)

13. Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention

15. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI

16. Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI

17. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

19. Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents

20. Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset

21. Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality

27. IMPACT OF SEX ON OUTCOMES AMONG PATIENTS WITH A PREVIOUS CORONARY ARTERY BYPASS GRAFT UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

30. IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

31. IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL

32. TICAGRELOR MONOTHERAPY AFTER PCI ACROSS THE SPECTRUM OF HIGH-RISK PATIENTS: A DEEP DIVE INTO THE TWILIGHT TRIAL

33. TCT-346 The Mega COMBO Collaboration: An Individual Patient Data Pooled Analysis of Patients Undergoing PCI With COMBO Stent

35. TCT-217 Predictors of Dyspnea in Patients Receiving Ticagrelor After PCI: Insights From the Twilight Trial

37. TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis

38. IMPACT OF TARGET VESSEL CHOICE ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH A PRIOR CORONARY ARTERY BYPASS GRAFT

39. PREVALENCE AND PROGNOSTIC IMPACT OF HIGH BLEEDING RISK STATUS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN CORONARY ARTERY DISEASE

43. PROGNOSTIC VALUE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PCI

44. TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY

Catalog

Books, media, physical & digital resources